<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a common <z:hpo ids='HP_0002664'>neoplasm</z:hpo> of haematopoietic pluripotent stem cells </plain></SENT>
<SENT sid="1" pm="."><plain>Although one third of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients evolve to <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), little is understood about the mechanisms responsible for this progression </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously detected the frequent loss of heterozygosity (LOH) on the short arm of chromosome 1 in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we examined the chromosomal arm 1p for allelic loss in the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, using 17 microsatellite markers spanning chromosome 1 in 20 patients who progressed from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>DNA was extracted from slides of bone marrow smears </plain></SENT>
<SENT sid="5" pm="."><plain>In each patient, DNA from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was analysed alongside DNA from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Allelic loss on 1p was observed in six of the 20 individuals (30%) </plain></SENT>
<SENT sid="7" pm="."><plain>Serial cytogenetic information was available in five of the six patients with LOH on 1p; no deletions in this region were detected </plain></SENT>
<SENT sid="8" pm="."><plain>Three samples showed LOH at <z:hpo ids='HP_0000001'>all</z:hpo> informative loci on 1p </plain></SENT>
<SENT sid="9" pm="."><plain>The other three samples showed LOH on at least one but not <z:hpo ids='HP_0000001'>all</z:hpo> loci on 1p with consensus regions of LOH located distal to D1S253 (1p36.3) and probably proximal to D1S496 (1p32-) </plain></SENT>
<SENT sid="10" pm="."><plain>Our results suggest that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor genes that play an important role in the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> may reside in at least two different regions on 1p </plain></SENT>
</text></document>